spacer
home > pmps > summer 2016 > the long arm of the regulator
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Long Arm of the Regulator

As the appetite grows in Western markets for healthy, natural foods and supplements that contribute to wellness, the opportunity for nutraceuticals is soaring. Public demand for superfoods and enriched functional sustenance is at an all-time high, while government and health providers are also promoting illness prevention through healthier lifestyles and dietary choices.

A recent report from Transparency Market Research suggests that the global nutraceuticals market will expand at a 7.30% compound annual rate between now and 2021 – from $182.60 billion in 2015 to $278.96 billion in five years, not least as a way of bringing chronic diseases under control (1).

The pharmaceutical industry, looking for new opportunities to dilute its reliance on expensive blockbuster drugs, is embracing nutraceuticals through acquisition or expansion of businesses to include a nutrition-oriented division. But where operations and staff have come from outside the pharma sector, there are likely to be gaps in those businesses’ understanding of the strict regulatory landscape they will be subject to.

Please see the full PDF for more details.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Peter Muller is Managing Director of Schlafender Hase (Americas). For the last 20 years, he has worked on software and process improvement projects with Fortune 500 companies from various industries: pharmaceutical, consumer goods, food, aerospace and defense. Peter has a wealth of experience working with international clients to define their organisation’s goals and help them leverage new technologies to achieve productivity gains, process improvements and cost savings.
spacer
Peter Muller
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement